Sometimes. But the real answer is not “yes” or “no.” It depends what you mean by cannabis ads, what the page says, what the user is being asked to do, and how much risk the account can tolerate.
People hear “Google Ads for cannabis” and assume there is a clean playbook. There isn’t. Some campaigns run. Some get flagged immediately. Some run for months, then one landing page edit, keyword expansion, sitelink, image swap, or footer change creates problems. This guide explains what actually survives, what usually breaks, and why cannabis Google Ads are narrower than normal paid search.
The uncomfortable part is this: Google Ads for cannabis is often a restraint test before it is a scale test. The business that can say “no” to risky keywords, aggressive claims, and tempting menu traffic usually has a better shot than the business trying to force a normal PPC playbook into a restricted category.
If you'd like to learn more about my background and why I take such a conservative approach to cannabis advertising, visit Meet Vee Popat & About ColaDigital. The way I think about Google Ads comes from more than 20 years in digital marketing and working exclusively with cannabis businesses since 2017.
Google Ads for cannabis is not normal Google Ads with a few banned words removed. That is where a lot of businesses get burned. A campaign can look clean in the ad preview and still carry risk because the landing page, site navigation, search terms, schema, images, or business model tells Google a different story.
The first question is not “Can we run cannabis ads?” The better question is: “What part of this offer can safely survive on Google Ads?” A medical clinic, a licensed dispensary, a CBD or hemp brand, and a cannabis software company do not sit in the same risk bucket. They may all say “cannabis,” but Google’s systems do not read them the same way.
In practice, the campaigns that have the best chance are usually narrower than the business owner wants. I understand why that creates frustration. Most operators are looking at the searches closest to a sale and thinking, "Why wouldn't we target those?" In almost every other industry, that logic makes sense.
Where I see businesses get into trouble is when they assume Google evaluates cannabis campaigns the same way it evaluates every other industry. The reality I've found is that restrictions on cannabis advertising leave less room for error.
Decisions that seem routine elsewhere, such as expanding keywords, testing new landing pages, or adding sitelinks, can carry different consequences in cannabis because they change how Google interprets the campaign.
That’s why volume alone is not a useful success metric. A campaign can attract more traffic while simultaneously becoming harder to keep stable. The challenge is not just generating clicks. It is generating clicks in a way that the campaign, landing page, and offer can continue to support over time.
Dispensaries feel this pressure more than anyone else because the searches that look the most valuable are often sitting closest to menus, product categories, pricing, deals, and shopping behaviour. I've seen operators focus entirely on increasing volume without realizing they were also increasing the likelihood of review friction at the same time.
Medical marijuana clinics usually have more room because the visitor journey revolves around eligibility, evaluations, consultations, and appointments. Ancillary businesses often have more flexibility because they are selling services rather than cannabis products directly. The challenge is understanding which part of the business Google is actually evaluating, not which part of the business you wish it would focus on.
CBD and hemp businesses often underestimate this as well. Some of the review issues I've seen had nothing to do with THC. The problem was the claims being made, the product framing, the checkout path, the benefit language, or the overall impression the landing page created once someone visited. Being outside the THC market does not automatically make the campaign easy.
The campaigns that tend to hold up best are usually the ones making the clearest promise. The keyword matches the page. The page matches the intent. The next step is obvious. Once the path becomes more complicated, the chances of something getting misread increase, and that is where stability often starts to disappear.
There is also a cost to instability that most teams underestimate. Every disapproval, pause, appeal, edit, and review cycle slows learning. You lose clean testing windows. You lose momentum. You may also train the account into a more sensitive review pattern if the same risky signals keep coming back.
That cost is not just annoying. It changes the economics. A campaign that spends two weeks learning, one week paused, three days under review, then restarts with edits is not getting the same test as a normal account. The reported CPC may look fine. The real cost includes lost data, lost timing, broken conversion volume, and the team hours spent trying to figure out what changed.
That is why the best cannabis Google Ads campaign is not always the most aggressive one. Sometimes the smaller campaign survives. Sometimes the less obvious page gets more stable delivery. Sometimes the highest-volume keyword is the keyword you should not touch.
Even when Google allows limited campaigns, jurisdiction still matters. For example, cannabis advertising laws in New York can shape what messaging and landing pages are viable. Google policy is only one layer. Legal context changes by market, so use this reference for broader context: cannabis advertising laws in the USA & Canada.
For the broader paid advertising picture, this guide to dispensary advertising explains how search intent, landing pages, and channel limits shape campaign results. If you need the commercial service layer, start with cannabis advertisements and dispensary advertising or the broader cannabis ad agency page. This page stays focused on the Google Ads reality.
Account continuity depends heavily on risk control. This cannabis advertising compliance guide explains common platform issues at a higher level. And if paid campaigns are already wasting spend, read why cannabis ads fail before assuming the budget is the problem.
Google doesn’t only read your headline. It reads the situation around the ad.
That distinction matters because I regularly see operators focus on the visible parts of the campaign while the actual risk sits somewhere else entirely. The headline gets reviewed. The CTA gets reviewed. The keyword gets reviewed. Meanwhile, the page template, navigation, footer links, schema, images, or site structure are quietly sending a completely different signal.
One thing I've learned after years working in cannabis marketing is that Google is often trying to answer a much simpler question than operators think.
One reason I spend so much time reviewing the entire pathway instead of only the ad itself is because I've seen small website changes create problems weeks after a campaign was approved. Those situations are frustrating because nothing appears to have changed from the advertiser's perspective, yet the account is no longer being interpreted the same way.
"What is this business actually trying to get someone to do?"
If the answer looks educational, informational, appointment-based, or service-focused, the path is usually easier to defend. If the answer starts looking like product shopping, THC commerce, menu browsing, pricing comparison, or direct purchase behaviour, the level of scrutiny tends to increase.
The frustrating part is that cannabis businesses often do not notice when they cross that line.
A campaign launches cleanly. Someone updates the navigation. A new footer link gets added. A product category appears in a related-post widget. A page that originally supported an evaluation or educational search slowly starts exposing more retail signals. None of those changes feel significant on their own. Collectively, they can completely change how Google diagnoses the destination.
I've seen situations where operators were convinced Google had suddenly changed its position on their campaign status, when in reality it was much less dramatic. There were just enough small changes accumulated that it no longer looked like the same pathway it started as.
That is why I spend a lot of time looking for contradictions. If the ad says one thing and the destination suggests something else, problems tend to appear eventually. Sometimes immediately. Sometimes months later. But the mismatch usually catches up with performance at some point.
One uncomfortable truth: approval is not the same thing as safety. A campaign can get approved and still be fragile. It can start delivering, collect data, and then hit a review later after a page change, keyword expansion, new sitelink, image update, policy sweep, or account-level classification change.
That is why cannabis Google Ads work is less about “magic wording” and more about reducing contradictions. If the ad says one thing and the site says another, expect problems. Maybe not today. Maybe next month. But eventually the mismatch tends to show up.
This is also why operators get frustrated. From their side, nothing changed. From the account’s side, plenty may have changed: the search terms got broader, the landing page was cached differently, a plugin updated schema, a new banner appeared, or a footer link started showing across the site.
Most disapprovals are not random. They feel random because the review message is usually vague, but the trigger is often sitting somewhere in the path. A word. A menu link. A product image. A CTA. A page template that was reused from a retail page. A search term that dragged the campaign into product intent.
For Canadian advertisers, local rules can add another layer beyond platform review. If campaigns are running in Canada, review Ontario cannabis advertising laws so the landing page and messaging stay aligned with jurisdiction-specific expectations.
Ad copy is only one layer. A lot of cannabis advertisers edit headlines over and over while the real problem is sitting on the landing page. Sometimes the ad is fine, but the page creates the problem. Sometimes the page is fine, but the keyword intent is too hot. Sometimes the destination was safe at launch, then a site update added product language later.
Another common issue is creep. A campaign starts clean. Then a new ad group gets added. Search terms broaden. Someone adds sitelinks. A landing page gets updated by a different team member. Two months later, the destination includes a product reference, a menu link, or a visual that was never reviewed for Google Ads.
That creep has a real business cost. The account pauses. The team appeals. The page gets edited. The campaign restarts. Then the data is messy because the test window was interrupted. This is how cannabis advertisers end up thinking Google Ads “doesn’t work” when the real issue is that the account never stayed stable long enough to get a clean read.
Creative also matters because platforms may flag direct product claims, product visuals, or language that sounds like a shortcut to purchase. See the Cannabis Ad Creative Rules guide for copy and visual patterns that reduce rejection risk without making the campaign sound empty.
The Google Ads paths that work in cannabis are usually boring on purpose. That is not a flaw. It is the point. The campaign has to be clear enough for the user and low-risk enough for review systems. If the offer needs too much explaining or feels too close to product sales, it is probably not a strong Google Ads fit.
The best campaign is often the one that leaves money on the table at first. That sounds wrong until you have watched a campaign get too ambitious, pull in risky searches, lose delivery, and burn the week trying to get back to where it started.
This is usually the cleanest path when the business is a medical clinic and the offer is evaluation, consultation, eligibility, or appointment booking. The page should feel like a healthcare service path, not a product recommendation page.
This can work when the topic answers a real question without pushing people straight into shopping. The mistake is making the guide too soft. If the topic is vague, traffic is cheap but weak. If the topic is too close to “buy now,” the campaign can become unstable.
For retailers, education-first pages can also support SEO. The same content that helps paid search stay cleaner can support organic rankings, internal links, and broader authority when it is written for real customer questions.
Brand defense is often the most practical Google Ads use case for cannabis retailers. The user is already looking for you. The intent is clearer. The keyword set is smaller. That does not make it risk-free, but it is usually less messy than trying to advertise THC product searches cold.
Ancillary companies can often run more normal-looking campaigns because they are not selling cannabis products directly. But they still need clarity. A software, packaging, compliance, staffing, or logistics page should not look like a disguised dispensary page.
CBD and hemp campaigns need their own restraint. The page should avoid medical promises, exaggerated wellness claims, and product wording that sounds like recreational cannabis. A checkout path can also change how the page is interpreted, even when the product is not THC flower or a dispensary menu.
| Framework | Best for | Primary risk | Stability lever |
|---|---|---|---|
| Medical evaluation | Clinics, patient pathways | Language drifting into product claims | Healthcare-style page with clear booking steps |
| Education-first | Retailers and brands building trust | Weak intent if the topic is too broad | Useful guide with a clean conversion path |
| Brand defense | Protecting branded searches | Landing page exposure to retail cues | Tight match types and safe sitelinks |
| Ancillary | B2B tools and services | Being misread as cannabis retail | Precise offer positioning and page hygiene |
| CBD or hemp | Selected non-THC product or wellness-adjacent offers | Claims, checkout cues, and unclear product positioning | Careful language, limited claims, and market-specific review |
Creative guardrails are not just there to please a policy reviewer. They protect the account from accidental drift. This matters because cannabis campaigns often break after small, normal-looking edits: a stronger CTA, a new sitelink, a better-looking image, a product term added for clarity. In most industries, that is optimization. In cannabis, it can be the thing that causes review problems.
The goal is not to make the ads bland. The goal is to make them accurate without pulling the account into a fight it does not need. There is a difference.
Use neutral visuals. Clean icons. Abstract shapes. Clinic-style photography if it matches the offer. Simple educational diagrams. Avoid buds, jars, packaging, smoking, vaping, gummies, rolling papers, or anything that makes the ad destination feel like product promotion.
Extensions can help performance, but they can also expose the wrong part of the site. Sitelinks should point to safer pages like “How It Works,” “Eligibility,” “Pricing,” “FAQs,” or a clean education page. Do not use extensions to send people into menus, deals, categories, or shopping paths.
This is where a lot of accounts get messy. The main landing page is careful. The sitelinks are not. Or the callout extensions use language the landing page avoided. Every visible asset should tell the same story.
Small copy changes deserve more respect in cannabis. “Learn how it works” and “Shop available products” may feel like normal CTA variations to a retail team. To the account, they can mean completely different things.
Landing pages are where cannabis Google Ads usually live or die. Not because the page has to be perfect. Because the page has to be consistent. If the ad promises education, the page cannot feel like shopping. If the ad promises an evaluation, the page cannot drift into product recommendations.
Bad landing pages do not always fail loudly. Sometimes they get approved but convert poorly. Sometimes they run for a while and then trigger a review. Sometimes they create low-quality leads because the user expected one thing and got another. This is why landing page work matters more in cannabis than in most standard paid search campaigns.
The sensitive parts are not always obvious. A hero may be fine, but the footer says “shop flower.” The body copy may be careful, but the image filename or alt text says “THC gummies.” The CTA may say “book a consultation,” but the breadcrumb or product schema says something else. In cannabis, the quiet parts of the page can be the problem.
Landing page quality also affects cost and conversion efficiency. Ads should lead to the right destination for the query, not the page the business wants to push hardest. For a deeper landing page breakdown, use cannabis advertising landing pages. For keyword-to-page mapping, see the PPC keyword intent mapping template.
Landing page hygiene is an operational process. Someone has to own the page. Someone has to review edits before they go live. Someone has to stop a well-meaning content update from adding product language to a page built for paid search. Treat the page like an ad asset, not a blog post that anyone can change casually.
A useful internal rule: if the page is connected to Google Ads, do not let general site edits touch it without review. Cannabis teams often lose stability from normal website maintenance, not from some dramatic campaign mistake.
These templates are not meant to be copied word for word. They show the shape of pages that are easier to defend because they keep the offer clear. The page should tell a simple story: who this is for, what happens next, what the user can do, and why the business is legitimate.
A clinic page should feel steady. It should not sound like it is trying to sell cannabis. The stronger angle is clarity: who qualifies, how the appointment works, what documentation may be needed, what happens after approval, and what the patient should expect.
An education page has to be useful enough to deserve the click. Thin “learn more” pages usually do not hold attention. Good pages answer the question directly, explain the tradeoffs, and help the reader avoid a mistake.
An ancillary page should separate itself from retail cannabis quickly. The more clearly the page explains the business problem, such as compliance workflow, packaging operations, staffing, software, or logistics, the less it feels like a disguised product-sales page.
In cannabis Google Ads, keyword research is not just about volume. It is about intent risk. A keyword can look profitable and still be wrong for Google Ads because the implied action is too close to restricted product purchase.
This is one of the hardest adjustments for operators. In normal search marketing, you chase bottom-funnel intent. In cannabis, the bottom-funnel phrase may be the phrase that creates the most trouble. “Buy weed near me” might be valuable demand, but it usually belongs to SEO, Maps, owned content, or other channels. Not a fragile Google Ads account.
This is where restraint becomes a performance lever. A smaller keyword set can produce better learning because the traffic is cleaner, the page match is tighter, and the account is not constantly being pulled into messy searches.
A practical way to build the list is to tag every keyword by intent: evaluation, education, brand, ancillary, CBD or hemp, or product purchase. Product purchase terms are usually not the Google Ads lane. That simple filter prevents a lot of bad decisions.
There is a budget lesson here too. High-risk keywords can waste money before they ever generate clean data. If the account spends half its time in review or matching into the wrong searches, the campaign never gets a fair test.
The goal is not to remove ambition. It is to earn the right to expand. Start with what the account can handle. Then widen only where the data and delivery stability support it.
Negative keywords are not just an optimization tactic in cannabis. They are part of account protection. Drift happens fast when broad match, loose phrase match, or mixed-intent ad groups start pulling in product shopping queries.
This is especially true after launch. The campaign may start with clean intent, then Google finds related searches that are not safe for the offer. If nobody is checking search terms, the account can quietly move into riskier territory while the team thinks performance is improving.
Do not wait until the campaign “has more data” if the wrong intent is obvious. In cannabis, letting bad intent run longer does not create better learning. It creates noise and sometimes review trouble.
One cannabis Google Ads approach does not fit every cannabis business. This is where generic advice gets dangerous. A clinic page, a dispensary page, and a B2B software page can all be “cannabis,” but they carry very different review signals.
Dispensaries have the least room because the business model itself is close to the restricted action: selling THC products. That does not mean every paid search idea is impossible. It means the safest uses are usually brand defense, education-first pages, and carefully controlled local intent that does not push directly into menus or deals.
For most dispensaries, SEO, Google Business Profile, and owned local pages still carry the heaviest product-intent demand. Google Ads can support around the edges, but it should not be treated like a normal retail PPC channel.
The operator mistake is trying to make Google Ads behave like the dispensary menu. That is usually the wrong fight. The better role is often protecting brand demand, answering pre-shopping questions, and supporting customer education without sending the account into direct THC sales signals.
Clinics have more room when the page is clearly about evaluation, eligibility, consultation, or an appointment process. The risk comes when the page starts sounding like product access, product outcomes, or a shortcut to cannabis. A clinic page should not borrow retail language just because it converts better in other channels.
Clinic campaigns also need honest measurement. A form fill is not the same as a booked consultation. A booked consultation is not the same as an approved patient. The campaign should be judged by the steps that matter to the actual operation.
CBD and hemp brands often assume they are outside the hard part. Sometimes they are. Sometimes they are not. The issue is usually claims and presentation. If the page promises relief, cure-like outcomes, intoxication-adjacent benefits, or uses a product page that feels too close to cannabis retail, the account can still run into trouble.
Ancillary businesses usually have the most flexibility because they are not selling cannabis products directly. Software, packaging, staffing, training, compliance, logistics, and B2B services can often be positioned more cleanly. Still, clarity matters. The offer should not look like a proxy for cannabis sales.
The big lesson: choose the ad path based on the business model, not the keyword volume. Dispensaries, clinics, CBD brands, hemp brands, and ancillary companies should not be using the same ads, same pages, or same measurement expectations. For businesses that need ongoing campaign management, channel planning, and platform-specific execution support, working with a specialized cannabis advertising agency is often very different from simply launching ads and hoping the platform figures everything out.
Account structure is a control layer. It keeps intent separated so the account does not blur safe traffic with risky traffic. In cannabis, that separation matters more than clever bidding or fancy account builds.
A messy account makes it hard to know what is working. A mixed ad group might contain brand searches, education searches, evaluation searches, and product-adjacent searches. When something gets disapproved, nobody knows which part caused it. When leads come in, nobody knows which intent produced them.
Smaller is often smarter at the start. Not forever. Just long enough to know what is actually stable. A tight account gives you cleaner search term data, clearer approval patterns, and fewer places for hidden retail signals to leak into the campaign.
If you need the service-side execution layer, the dedicated cannabis Google Ads management page covers how account support is handled. This guide stays focused on what the channel can realistically do.
When a cannabis campaign gets disapproved, the worst move is panic-editing everything. That creates more confusion. You need to know what changed, what was reviewed, and where the risky signal came from.
A lot of teams keep rewriting headlines because that is the easiest thing to see. But the issue may be the destination page, a sitelink, a footer link, a recent site edit, an image, a search term, or a mismatch between the keyword and page.
If the keyword implies product purchase, even a clean page may struggle. Tighten match types. Remove mixed intent. Expand negatives. Make the campaign smaller if that is what keeps it cleaner.
Once the path is consistent from keyword to ad to page, resubmit and monitor. Avoid changing ten things at once. If delivery comes back, you need to know what fixed it. Otherwise the same problem usually returns.
After approval, do not treat the campaign as finished. Watch search terms, page edits, new extensions, conversion paths, and delivery swings. A lot of cannabis Google Ads problems start after the campaign is already live.
This is also where paid media and site teams need to talk. A page can be safe on Monday and risky on Friday if someone updates the site without knowing it feeds Google Ads.
Lead count can lie in cannabis. A form fill is not always a qualified customer. A call is not always a booked appointment. A click can look cheap because the campaign drifted into the wrong intent.
Google Ads reporting has to separate early activity from real outcomes. This is especially important for clinics, where the difference between “lead submitted” and “appointment booked” changes the whole performance story. It also matters for ancillary brands, where the wrong traffic can fill a pipeline with unqualified inquiries.
Whenever possible, track the difference between a lead and a booked outcome. Even a basic CRM stage update can make reporting more honest. If the business cannot track booked outcomes yet, use qualified call duration, appointment confirmations, or manual lead review to get closer to reality.
Policy stability belongs in the KPI stack too. A campaign that converts well for two weeks, then spends the next two weeks in review, is not really stable performance. In cannabis, delivery consistency is part of the result.
There is also a reporting trap: teams celebrate cheap leads while ignoring why sales, bookings, or qualified calls are not moving. In restricted categories, the cheaper traffic is often cheaper for a reason. It may be looser, less qualified, or coming from intent the business should not have targeted in the first place.
| Metric | What it tells you | Why it matters in cannabis |
|---|---|---|
| Booked appointment rate | Lead quality and funnel alignment | Prevents inflated lead reporting |
| Delivery stability | Whether the campaign can keep running | Shows risk before it becomes a bigger account problem |
| Qualified call duration | True intent quality | Filters accidental clicks and low-intent inquiries |
| Clean learning window | How long the account ran without interruption | Shows whether the test was actually valid |
Google Ads should not carry the whole cannabis growth plan. That is too much pressure for a channel with restricted intent, review risk, and uneven delivery. The better move is to give each channel a clear job.
| Channel | Best for | Limitations | How it fits the system |
|---|---|---|---|
| Google Ads | Allowed intent capture, brand defense, clinic pathways, selected education pages | Review risk and limited product-intent room | Use narrow campaigns and protect account continuity |
| SEO | Local rankings, product-intent demand, education, organic discovery | Time to compound results | Foundation channel for durable demand capture |
| Programmatic | Reach across CTV, display, native, and awareness campaigns | Often higher funnel | Builds demand where search and social are limited |
For many cannabis businesses, the practical mix is less complicated than people make it. SEO captures searches that paid media should not be chasing. Google Ads protects the demand that can realistically be captured through search. Programmatic helps build awareness and familiarity in markets where social and search have obvious limitations.
Google Ads performs best when it has a clearly defined job. I’ve learned this after almost a decade managing cannabis Google Ads for brands, dispensaries, and medical marijuana doctors in the USA and Canada.
This may sound obvious, but it is where many cannabis businesses run into trouble. Search campaigns are often expected to generate awareness, create demand, educate new audiences, protect branded traffic, and drive conversions at the same time. That is a heavy burden for a channel already operating inside policy restrictions.
Google Ads is usually strongest when demand already exists. Someone is researching eligibility requirements. Someone is comparing dispensaries. Someone is actively searching for a medical cannabis doctor. Paid search works best when intent already exists and the campaign can connect that intent to the right landing page.
The mistake is treating Google Ads as a universal growth channel. In cannabis, some searches are simply better captured elsewhere. Product-focused demand, local discovery, educational research, and broader awareness often require different channels, assets, or strategies.
That does not make Google Ads less valuable for cannabis brands and dispensaries. It makes its role clearer.
Cannabis businesses that get the most from Google Ads are not always the businesses spending the most. They're the businesses that understand which searches deserve paid traffic and which searches don't. That distinction sounds small, but in cannabis, it can completely change how stable, measurable, and profitable a campaign becomes over time.
That way of thinking extends well beyond Google Ads. Whether I'm reviewing SEO, paid media, website architecture, or a broader growth strategy, I start with the same question: what is actually limiting the business right now? Too many marketing recommendations jump straight to tactics before diagnosing the real constraint. If you'd like to see the framework behind those decisions, read our Cannabis Marketing Methodology.
For channel planning, compare cannabis SEO vs paid media. If Meta is part of the discussion, the cannabis Facebook ads management page explains why social has its own restrictions and practical limits.
In my experience with cannabis advertising on Google, the fastest way to create problems is to launch wider than the business has earned the right to go. I understand why operators want to move quickly. If the first signs look promising, the natural reaction is to add more keywords, expand targeting, test new pages, and push for more volume.
I've watched that happen many times, and it is usually where things start getting messy.
The problem is that early performance can create false confidence. A campaign may look stable after a couple of weeks, but that doesn't mean it has survived enough conditions to be trusted yet. The campaign has not seen enough search terms yet. The landing page has not been tested long enough. The review systems have not seen enough changes.
That is why this rollout is built around restraint. Not because restraint sounds nice. Because uncontrolled expansion can wreck the test before you know what was actually working in the first place.
This is not the flashiest rollout. It is the one more likely to survive long enough to learn something useful.
Use this checklist before launching or scaling a cannabis-adjacent Google Ads campaign. It is not a legal review. It is a practical pre-flight check for the mistakes that usually create disapprovals, bad traffic, or account instability.
If Google Ads keeps breaking, the problem may not be the budget. It may not even be the ad copy. It may be that the campaign is trying to do something Google does not want that account, page, or offer to do.
Some of the most frustrating Google Ads situations I've reviewed had nothing to do with budget. In many cases, the campaign was generating clicks, impressions, and even conversions. On the surface, everything looked fine.
The issue usually appeared one layer deeper.
Search terms started drifting away from the original intent. New keywords were added without considering how they changed the traffic profile. Landing pages evolved over time and no longer matched the searches that triggered the ads. Sitelinks, extensions, navigation changes, and page updates slowly pushed the campaign away from the role it was originally built to perform.
That’s what makes Google Ads instability difficult to diagnose. The campaign rarely breaks all at once. More often, performance becomes harder to explain. Lead quality changes. Conversion rates fluctuate. Search term reports become less predictable. Teams start making bigger changes in response, which often makes the diagnosis even harder.
Before increasing budget, expanding targeting, or rebuilding campaigns, look at whether the original intent path is still intact. The keyword, search term, ad, landing page, and conversion goal should all support the same outcome. If they no longer do, adding more spend usually magnifies the problem instead of solving it.
The win is not always “scale harder.” Sometimes the win is keeping the account live, getting cleaner data, protecting brand demand, and letting SEO or programmatic handle the searches Google Ads should not chase.
If you're unsure whether the issue is Google Ads, the landing page, keyword intent, or something else entirely, I'd rather help identify the real constraint first than recommend changes that only add more complexity to the account.
